Kavita Singh1,2, K M Venkat Narayan3, Karen Eggleston4. 1. Public Health Foundation of India, Plot number 47, Sector 44, Gurugram, Haryana, 122002, India. kavita@ccdcindia.org. 2. Centre for Chronic Disease Control, New Delhi, India. kavita@ccdcindia.org. 3. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 4. Stanford University, Stanford, CA, USA.
Abstract
PURPOSE OF REVIEW: To critically assess and identify gaps in the current literature on the economic impact of diabetes in South Asia. RECENT FINDINGS: The total annual (direct medical and non-medical and indirect) costs for diabetes care in South Asia range from $483-$2637 per patient, and on an average 5.8% of patients with diabetes suffer catastrophic spending i.e. when households reduce basic expenditure by 40% to cope with healthcare costs. The mean direct costs per patient are positively associated with a country's gross domestic product (GDP) per capita, although there is wide heterogeneity across South Asian countries. With an estimated 84 million people suffering from diabetes in South Asia, diabetes imposes a substantial economic burden on individuals, families, and society. Since the disease burden increasingly occurs in the most productive midlife period, it adversely affects workforce productivity and macroeconomic development. Diabetes-related complications lead to markedly higher treatment costs, causing catastrophic medical spending for many households, thus underscoring the importance of preventing diabetes-related complications.
PURPOSE OF REVIEW: To critically assess and identify gaps in the current literature on the economic impact of diabetes in South Asia. RECENT FINDINGS: The total annual (direct medical and non-medical and indirect) costs for diabetes care in South Asia range from $483-$2637 per patient, and on an average 5.8% of patients with diabetes suffer catastrophic spending i.e. when households reduce basic expenditure by 40% to cope with healthcare costs. The mean direct costs per patient are positively associated with a country's gross domestic product (GDP) per capita, although there is wide heterogeneity across South Asian countries. With an estimated 84 million people suffering from diabetes in South Asia, diabetes imposes a substantial economic burden on individuals, families, and society. Since the disease burden increasingly occurs in the most productive midlife period, it adversely affects workforce productivity and macroeconomic development. Diabetes-related complications lead to markedly higher treatment costs, causing catastrophic medical spending for many households, thus underscoring the importance of preventing diabetes-related complications.
Entities:
Keywords:
Cost-of-illness studies; Diabetes mellitus; Economic impact; South Asia
Authors: Mohammed K Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A Patel; Roopa Shivashankar; Vamadevan S Ajay; A G Unnikrishnan; V Usha Menon; Premlata K Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Masood; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K M Venkat Narayan; Nikhil Tandon Journal: Ann Intern Med Date: 2016-07-12 Impact factor: 25.391
Authors: Rui Li; Shuli Qu; Ping Zhang; Sajal Chattopadhyay; Edward W Gregg; Ann Albright; David Hopkins; Nicolaas P Pronk Journal: Ann Intern Med Date: 2015-09-15 Impact factor: 25.391
Authors: Alison K Wright; Evangelos Kontopantelis; Richard Emsley; Iain Buchan; Naveed Sattar; Martin K Rutter; Darren M Ashcroft Journal: Diabetes Care Date: 2016-12-20 Impact factor: 19.112
Authors: Padam Kanta Dahal; Lal B Rawal; Rashidul Alam Mahumud; Grish Paudel; Tomohiko Sugishita; Corneel Vandelanotte Journal: Int J Environ Res Public Health Date: 2022-08-30 Impact factor: 4.614